MaxCyte stockholders approve 2022 equity incentive plan adding ~2M new shares

MAXCYTE, INC.

Stockholders voted 58.3M for, 8.0M against, 11k abstain to approve the 2022 Equity Incentive Plan.
Plan adds 1,928,000 new shares plus shares rolled over from prior plans; total reserve not specified.
Three directors re-elected: Doug Doerfler, Yasir Al-Wakeel, Rekha Hemrajani.
CohnReznick LLP ratified as auditor for FY2022 with 71.55M votes for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.